# Farallon Capital Management, 13F Q2 2026

Farallon Capital Management, L.L.C. reported $21.7 billion in 13F securities across 89 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was State STR SPDR S&P 500 ETF T at $4.5 billion, 20.7% of the reported value. Since Q1 2026 it opened 23 new positions and exited 107.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $21,675,731,270
- Positions: 89
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 909661
- Form 13F file number: 028-03896
- CRD number: 107322
- Business address: One Maritime Plaza Suite 2100, San Francisco, CA 94111
- SEC filing: [0000908834-26-000432](https://www.sec.gov/Archives/edgar/data/909661/000090883426000432/0000908834-26-000432-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/farallon-capital-management-l-l-c-107322)

## Top 25 holdings by value

The largest of 89 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| State STR SPDR S&P 500 ETF T | TR UNIT (put) | 6,000,000 | $4.48 billion | New |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 13,550,796 | $2.54 billion | -54,000 |
| [Electronic Arts Inc](https://specstream.ai/data/institutional-holders/electronic-arts-inc-285512109) | COM | 7,919,500 | $1.62 billion | +449,500 |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 10,743,063 | $800.1 million | +1,377,600 |
| [Protagonist Therapeutics Inc](https://specstream.ai/data/institutional-holders/protagonist-therapeutics-inc-74366e102) | COM | 6,348,906 | $778.2 million | No change |
| [Exelixis Inc](https://specstream.ai/data/institutional-holders/exelixis-inc-30161q104) | COM | 13,468,010 | $732.8 million | +357,000 |
| [Liquidia Corporation](https://specstream.ai/data/institutional-holders/liquidia-corporation-53635d202) | COM NEW | 8,365,038 | $666.9 million | -291,000 |
| [Amazon Com Inc](https://specstream.ai/data/institutional-holders/amazon-com-inc-023135106) | COM | 2,632,994 | $627.5 million | -1,585,400 |
| [Lantheus Hldgs Inc](https://specstream.ai/data/institutional-holders/lantheus-hldgs-inc-516544103) | COM | 5,583,479 | $619.4 million | No change |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 2,218,366 | $602.2 million | -989,000 |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 1,270,532 | $528.1 million | -551,174 |
| [Thermo Fisher Scientific Inc](https://specstream.ai/data/institutional-holders/thermo-fisher-scientific-inc-883556102) | COM | 1,049,185 | $526 million | +167,700 |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 14,309,000 | $506.4 million | +4,634,000 |
| [Aon PLC](https://specstream.ai/data/institutional-holders/aon-plc-g0403h108) | SHS CL A | 1,382,562 | $458.6 million | -1,130,076 |
| [Boston Scientific Corp](https://specstream.ai/data/institutional-holders/boston-scientific-corp-101137107) | COM | 10,521,184 | $449 million | +3,050,500 |
| [Broadcom Inc](https://specstream.ai/data/institutional-holders/broadcom-inc-11135f101) | COM | 1,151,800 | $435.1 million | -627,700 |
| [Microsoft Corp](https://specstream.ai/data/institutional-holders/microsoft-corp-594918104) | COM | 1,112,863 | $415.1 million | -1,231,916 |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 12,277,000 | $383.8 million | +3,179,589 |
| [KKR & Co Inc](https://specstream.ai/data/institutional-holders/kkr-co-inc-48251w104) | COM | 4,118,300 | $378 million | -553,500 |
| [Synopsys Inc](https://specstream.ai/data/institutional-holders/synopsys-inc-871607107) | COM | 829,600 | $370.1 million | -383,700 |
| [Beam Therapeutics Inc](https://specstream.ai/data/institutional-holders/beam-therapeutics-inc-07373v105) | COM | 10,236,396 | $351.3 million | +101,700 |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 8,989,098 | $336.4 million | +651,000 |
| [Grail Inc](https://specstream.ai/data/institutional-holders/grail-inc-384747101) | COM | 4,161,584 | $284.1 million | +907,900 |
| [Wabtec](https://specstream.ai/data/institutional-holders/wabtec-929740108) | COM | 894,503 | $241.2 million | -714,900 |
| [Immunovant Inc](https://specstream.ai/data/institutional-holders/immunovant-inc-45258j102) | COM | 5,805,000 | $223.7 million | +4,259,000 |

## New positions in Q2 2026

23 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| State STR SPDR S&P 500 ETF T | TR UNIT (put) | 6,000,000 | $4.48 billion |
| Ishares TR | ISHARES SEMICDTR (put) | 130,000 | $83.3 million |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 2,368,200 | $64.8 million |
| [Novartis AG](https://specstream.ai/data/institutional-holders/novartis-ag-66987v109) | SPONSORED ADR | 363,000 | $56.9 million |
| CG Oncology Inc | COM (call) | 400,000 | $28.4 million |
| [Warby Parker Inc](https://specstream.ai/data/institutional-holders/warby-parker-inc-93403j106) | CL A COM | 828,000 | $25.1 million |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 1,100,000 | $24.2 million |
| [Axalta Coating Sys LTD](https://specstream.ai/data/institutional-holders/axalta-coating-sys-ltd-g0750c108) | COM | 478,000 | $16.4 million |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 71,000 | $15.3 million |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 2,250,000 | $15.3 million |
| [Mobia Med Inc](https://specstream.ai/data/institutional-holders/mobia-med-inc-60705v103) | COMMON STOCK | 1,128,557 | $15.1 million |
| [Strategy Inc](https://specstream.ai/data/institutional-holders/strategy-inc-594972an1) | NOTE 2.250% 6/1 (principal) | 15,000,000 | $14.2 million |
| [Alamar Biosciences Inc](https://specstream.ai/data/institutional-holders/alamar-biosciences-inc-010911105) | COMMON STOCK | 462,900 | $12.5 million |
| [Inflarx NV](https://specstream.ai/data/institutional-holders/inflarx-nv-n44821101) | COM | 3,325,000 | $7.4 million |
| [Scotts Miracle-Gro Co](https://specstream.ai/data/institutional-holders/scotts-miracle-gro-co-810186106) | CL A | 88,000 | $6 million |
| [Waystar HLDG Corp](https://specstream.ai/data/institutional-holders/waystar-hldg-corp-946784105) | COM | 264,900 | $5.4 million |
| [Brunswick Corp](https://specstream.ai/data/institutional-holders/brunswick-corp-117043109) | COM | 61,000 | $5.1 million |
| [Gentex Corp](https://specstream.ai/data/institutional-holders/gentex-corp-371901109) | COM | 199,000 | $5 million |
| [Idexx Labs Inc](https://specstream.ai/data/institutional-holders/idexx-labs-inc-45168d104) | COM | 9,000 | $4.7 million |
| [Commercial Metals Co](https://specstream.ai/data/institutional-holders/commercial-metals-co-201723103) | COM | 67,000 | $4.2 million |
| [Jatt II Acquisition Corp](https://specstream.ai/data/institutional-holders/jatt-ii-acquisition-corp-g50765109) | ORD SHS | 300,000 | $3.4 million |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 415,000 | $3.2 million |
| [Strategy Inc](https://specstream.ai/data/institutional-holders/strategy-inc-594972au5) | NOTE 3/0 (principal) | 2,632,000 | $2.3 million |

## Positions exited in Q2 2026

107 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| State STR SPDR S&P 500 ETF T | PUT (put) | 2,300,000 | $1.50 billion |
| Invesco Exchange Traded FD T | S&P500 EQL WGT (put) | 3,600,000 | $690.9 million |
| [Schwab Charles Corp](https://specstream.ai/data/institutional-holders/schwab-charles-corp-808513105) | COM | 3,955,657 | $371.8 million |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k107) | CAP STK CL C | 996,231 | $285.8 million |
| [Visa Inc](https://specstream.ai/data/institutional-holders/visa-inc-92826c839) | COM CL A | 840,710 | $254.1 million |
| [Disney Walt Co](https://specstream.ai/data/institutional-holders/disney-walt-co-254687106) | COM | 2,401,591 | $231.5 million |
| [Mastercard Incorporated](https://specstream.ai/data/institutional-holders/mastercard-incorporated-57636q104) | CL A | 435,071 | $217.4 million |
| [McKesson Corp](https://specstream.ai/data/institutional-holders/mckesson-corp-58155q103) | COM | 234,300 | $202.8 million |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 4,809,000 | $191 million |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 3,580,818 | $137.1 million |
| [Tenet Healthcare Corp](https://specstream.ai/data/institutional-holders/tenet-healthcare-corp-88033g407) | COM NEW | 452,153 | $85.3 million |
| [Cardinal Health Inc](https://specstream.ai/data/institutional-holders/cardinal-health-inc-14149y108) | COM | 368,000 | $77.8 million |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 1,261,000 | $73.3 million |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 836,000 | $70.2 million |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 674,000 | $45.6 million |
| [Bitwise 10 Crypto Index ETF](https://specstream.ai/data/institutional-holders/bitwise-10-crypto-index-etf-091749101) | UNIT BENEFICIAL | 603,000 | $26.9 million |
| [Royalty Pharma PLC](https://specstream.ai/data/institutional-holders/royalty-pharma-plc-g7709q104) | SHS CLASS A | 493,000 | $23.6 million |
| [Ceco Environmental Corp](https://specstream.ai/data/institutional-holders/ceco-environmental-corp-125141101) | COM | 234,000 | $13.9 million |
| CG Oncology Inc | CALL (call) | 200,000 | $13.5 million |
| [GDS Hldgs LTD](https://specstream.ai/data/institutional-holders/gds-hldgs-ltd-36165l108) | SPONSORED ADS | 292,000 | $11.8 million |
| [Formfactor Inc](https://specstream.ai/data/institutional-holders/formfactor-inc-346375108) | COM | 56,500 | $5.5 million |
| [Mastec Inc](https://specstream.ai/data/institutional-holders/mastec-inc-576323109) | COM | 17,000 | $5.5 million |
| [Entegris Inc](https://specstream.ai/data/institutional-holders/entegris-inc-29362u104) | COM | 45,500 | $5.3 million |
| [Citigroup Inc](https://specstream.ai/data/institutional-holders/citigroup-inc-172967424) | COM NEW | 47,000 | $5.3 million |
| [Hyatt Hotels Corp](https://specstream.ai/data/institutional-holders/hyatt-hotels-corp-448579102) | COM CL A | 36,000 | $5.2 million |

## Also on SpecStream

- [Farallon Capital Management, L.L.C. Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/909661/000090883426000432/0000908834-26-000432-index.htm)
- [Farallon Capital Management, L.L.C. investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/farallon-capital-management-l-l-c-107322)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in San Francisco, California

- [Advertising agencies in San Francisco, California](https://specstream.ai/data/businesses/advertising-agencies/san-francisco-california-united-states)
- [Vegetarian restaurants in San Francisco, California](https://specstream.ai/data/businesses/vegetarian-restaurants/san-francisco-california-united-states)
- [Steakhouses in San Francisco, California](https://specstream.ai/data/businesses/steakhouses/san-francisco-california-united-states)
- [Salad bars in San Francisco, California](https://specstream.ai/data/businesses/salad-bars/san-francisco-california-united-states)
- [Public health clinics in San Francisco, California](https://specstream.ai/data/businesses/public-health-clinics/san-francisco-california-united-states)
- [Plumbers in San Francisco, California](https://specstream.ai/data/businesses/plumbers/san-francisco-california-united-states)
